Support us

A medicine to treat or prevent a disease is the pinnacle of human scientific endeavour

Help us extend that gift to those most in need
–Mark Sullivan AO, Founder, Medicines Development for Global Health
Lime green custom graphic
The problem

There is a group of diseases that affect more than 1.7 billion people worldwide and cause devastating health, economic and social consequences.

The World Health Organization has designated these diseases ‘neglected’ to illustrate how little money is spent on them.

At Medicines Development for Global Health, we focus on these diseases because we know it is important for them to be prevented and treated, and one day even eliminated.

When a neglected disease is eliminated, the benefits are abundant. It relieves physical pain, disability and stigmatisation; it boosts productivity, economies and school attendance; and it increases opportunities for women and children who are disproportionately affected by these diseases.

But the truth is that developing new medicines is expensive.

Lime green graphic with four dots with arrow facing downElephantiasis

Our model is resource-efficient and collaborative and we can bring medicines through to market at significantly less cost than for-profit pharmaceutical companies.

But it is still expensive to give the gift of a new medicine. It costs us (USD):

$1.5M - $10M

to run one clinical trial


to manufacture one batch of medicine


to support one participant in a clinical trial


to provide clinical trial supplies to one site

We have the expertise and tools required to develop and deliver medicines for the treatment of numerous neglected diseases, and there is potential for millions of people to benefit from our work. But we need your support.

Every gift we receive, no matter how large or small, will help us in our mission to eliminate neglected diseases. 

To learn more about our transformational work and how you can support us, please contact us.

Did you know that Nigeria alone could gain approximately US$19 billion in increased productivity by meeting its 2030 elimination targets for five neglected diseases?